Clinical Trial Update: A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the long-term effects of TEV-48574 in adults with moderate-to-severe Crohn's disease or ulcerative colitis; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• TEV-48574

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Crohn Disease, Colitis, Ulcerative | Phase 2 | Status: ACTIVE_NOT_RECRUITING